Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Net Income towards Common Stockholders: 2011-2012

Historic Net Income towards Common Stockholders for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to -$7.4 million.

  • Sonoma Pharmaceuticals' Net Income towards Common Stockholders rose 24.93% to -$1.9 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$5.4 million, marking a year-over-year increase of 24.56%. This contributed to the annual value of -$7.4 million for FY2012, which is 6.50% up from last year.
  • As of FY2012, Sonoma Pharmaceuticals' Net Income towards Common Stockholders stood at -$7.4 million, which was up 6.50% from -$7.9 million recorded in FY2011.
  • Sonoma Pharmaceuticals' Net Income towards Common Stockholders' 5-year high stood at -$7.4 million during FY2012, with a 5-year trough of -$7.9 million in FY2011.
  • For the 2-year period, Sonoma Pharmaceuticals' Net Income towards Common Stockholders averaged around -$7.7 million, with its median value being -$7.7 million (2011).
  • Data for Sonoma Pharmaceuticals' Net Income towards Common Stockholders shows a peak YoY increased of 6.50% (in 2012) over the last 5 years.
  • Sonoma Pharmaceuticals' Net Income towards Common Stockholders (Yearly) stood at -$7.9 million in 2011, then climbed by 6.50% to -$7.4 million in 2012.